Company profile for Defender Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Defender Pharmaceuticals, Inc., located in St. Louis, MO, is a privately held life sciences company focused on discovering, developing and commercializing medicines to help safeguard health across civilian and military populations. Our work with the Department of Defense, NASA, the Department of Veterans Affairs, and other institutions advance our mission to improve the health of patients and help make the world a more secure...
Defender Pharmaceuticals, Inc., located in St. Louis, MO, is a privately held life sciences company focused on discovering, developing and commercializing medicines to help safeguard health across civilian and military populations. Our work with the Department of Defense, NASA, the Department of Veterans Affairs, and other institutions advance our mission to improve the health of patients and help make the world a more secure place.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
12935 N Outer Forty Rd Suite #212 St. Louis, MO 63141
Telephone
Telephone
+1 3146971330
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Defender gets CRL from FDA on motion sickness nasal gel
Defender gets CRL from FDA on motion sickness nasal gel

31 Jan 2024

// Kevin Dunleavy FIERCE PHARMA

https://www.fiercepharma.com/pharma/fda-rejects-defenders-motion-sickness-nasal-gel-candidate#:~:text=A%20nasal%20gel%20version%20of%20the%20motion%20sickness%20drug%20scopolamine,and%20vomiting%20induced%20by%20motion.

Kevin Dunleavy FIERCE PHARMA
31 Jan 2024

https://www.globenewswire.com/news-release/2024/01/30/2820312/0/en/Defender-Pharmaceuticals-Receives-Complete-Response-Letter-from-the-U-S-Food-and-Drug-Administration-for-its-Intranasal-Scopolamine-DPI-386-New-Drug-Application-for-the-Prevention-.html

GLOBENEWSWIRE
30 Jan 2024

https://www.globenewswire.com//news-release/2023/10/24/2765559/0/en/Defender-Pharmaceuticals-Announces-Collaboration-with-NASA-on-Two-Phase-2-Clinical-Trials-Investigating-DPI-386-s-Ability-to-Mitigate-G-transition-Induced-Motion-Sickness-and-Enhan.html

GLOBENEWSWIRE
24 Oct 2023

https://www.globenewswire.com//news-release/2023/09/26/2749419/0/en/FDA-Accepts-Defender-Pharmaceuticals-New-Drug-Application-for-Intranasal-Scopolamine-Gel.html

GLOBENEWSWIRE
26 Sep 2023

https://www.globenewswire.com/news-release/2023/08/10/2722946/0/en/Defender-Pharmaceuticals-Phase-3-Motion-Sickness-Trial-Results-Selected-for-Presentation-at-2023-Military-Health-System-Research-Symposium-MHSRS.html

GLOBENEWSWIRE
10 Aug 2023

https://www.globenewswire.com/news-release/2023/07/31/2715262/0/en/Defender-Pharmaceuticals-Announces-Exclusive-License-Agreement-with-the-U-S-Army-for-the-Development-of-Products-to-Treat-Tropical-Diseases.html

GLOBENEWSWIRE
31 Jul 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty